Microbiotica

Clinical-stage UK biopharma developing oral microbiome medicines; its Series C first close funds a Phase 2 ulcerative colitis trial.

View on the globe

$48MEquity raised in 2025–20262025 — · 2026 $48M · 1 equity round
$48MEquity raised, all time1 equity round sourced so far
—Latest valuationnot disclosed

Rounds over time log-scaled amounts

Funding history: 1 round from 16 Oct 2026 to 16 Oct 2026, $48M equity disclosed. Earlier rounds exist but are not sourced.16 Oct 2026: Series C (first close), $48M$1M$3M$10M$30M$100MEarlier rounds exist but are not sourced yet← earlier rounds not sourcedest. 2016Q2Q3Q42027Q2Q3Equity round16 Oct 2026 · Series C (first close) · $48M · led by British Business BankSeries C · $48M
Funding history: 1 round from 16 Oct 2026 to 16 Oct 2026, $48M equity disclosed. Earlier rounds exist but are not sourced.16 Oct 2026: Series C (first close), $48M$1M$3M$10M$30M$100MEarlier rounds exist but are not sourced yetearlier rounds not sourced’16Q2Q3Q42027Q2Q3Equity round16 Oct 2026 · Series C (first close) · $48M · led by British Business Bank$48M

Funding history 1 round · 1 source

Earlier rounds not yet sourced. Microbiotica was founded in 2016 and raised before 16 Oct 2026; only the rounds below are sourced so far, so its all-time equity total understates its history.

  1. Series C (first close)
    Amount$48MGBP 36M
    Post-money—
    ◔ Reported
    Lead
    British Business Bank
    Also
    Tencent, IP Group, Cambridge Innovation Capital, Flerie Invest, Seventure Partners
    Note
    First close of a GBP 36M (USD 48M as stated in the announcement) Series C. All existing Series B investors also took part. Not a final close; no later close found. Valuation not disclosed. Pre- or post-money not applicable. Lead per the article: British Business Bank. The BBB and company releases returned 403 / were not opened, so only one secondary source is recorded. Verified 2026-11-16: BioIndustry article gives Series C first close (16 Oct 2026, lead British Business Bank, all Series B investors took part) and 2016 spin-out from the Wellcome Sanger Institute. HQ from company site contact page: Chesterford Research Park, Little Chesterford, Cambridge CB10 1XL (city centre coordinates used). Company news page 404; BBB release not opened.
    Sources
  2. Earlier rounds not yet sourced

Investors 6

  • British Business Bank1
  • Cambridge Innovation Capital
  • Flerie Invest
  • IP Group
  • Seventure Partners
  • Tencent

Highlighted investors led at least one equity round; the number is equity rounds taken part in.

Related companies shared investors

Also in the Cambridge hub see on the globe

Figures in USD at the time of each round. See the methodology for how rounds are sourced and verified. Microbiotica and its logo are trademarks of their owners, used here for identification only.